347 related articles for article (PubMed ID: 8150024)
1. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
3. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Histochem J; 1993 Sep; 25(9):648-63. PubMed ID: 8226103
[TBL] [Abstract][Full Text] [Related]
4. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
Vinores SA; Küchle M; Derevjanik NL; Henderer JD; Mahlow J; Green WR; Campochiaro PA
Histol Histopathol; 1995 Oct; 10(4):913-23. PubMed ID: 8574012
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
6. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
7. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
8. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
Luna JD; Chan CC; Derevjanik NL; Mahlow J; Chiu C; Peng B; Tobe T; Campochiaro PA; Vinores SA
J Neurosci Res; 1997 Aug; 49(3):268-80. PubMed ID: 9260738
[TBL] [Abstract][Full Text] [Related]
9. An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells.
Vinores SA; Sen H; Campochiaro PA
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1870-8. PubMed ID: 1582791
[TBL] [Abstract][Full Text] [Related]
10. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
12. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
14. Rat model for anterior segment intraocular surgery induced blood-retinal barrier breakdown.
Xie MS; Xu GX; Huang Y
Ophthalmologica; 2008; 222(1):42-7. PubMed ID: 18097180
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
[TBL] [Abstract][Full Text] [Related]
17. Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier.
Nakashima T; Tomi M; Katayama K; Tachikawa M; Watanabe M; Terasaki T; Hosoya K
J Neurochem; 2004 Jun; 89(6):1454-61. PubMed ID: 15189348
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase expression in human diabetic retina and retinal pigment epithelium.
Vinores SA; Campochiaro PA; Williams EH; May EE; Green WR; Sorenson RL
Diabetes; 1988 Dec; 37(12):1658-64. PubMed ID: 3142801
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
20. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
